{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T03:20:04Z","timestamp":1779938404797,"version":"3.53.1"},"reference-count":60,"publisher":"SAGE Publications","issue":"s1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2018,6,12]]},"DOI":"10.3233\/jad-179903","type":"journal-article","created":{"date-parts":[[2018,3,16]],"date-time":"2018-03-16T11:38:11Z","timestamp":1521200291000},"page":"S397-S404","source":"Crossref","is-referenced-by-count":19,"title":["Brain Aging and Late-Onset Alzheimer\u2019s Disease: A Matter of Increased Amyloid or Reduced Energy?"],"prefix":"10.1177","volume":"64","author":[{"given":"Patrizia","family":"Mecocci","sequence":"first","affiliation":[{"name":"Department of Medicine, Institute of Gerontology and Geriatrics, University of Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Baroni","sequence":"additional","affiliation":[{"name":"Department of Medicine, Institute of Gerontology and Geriatrics, University of Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Senin","sequence":"additional","affiliation":[{"name":"Department of Medicine, Institute of Gerontology and Geriatrics, University of Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Boccardi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Institute of Gerontology and Geriatrics, University of Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-179903_ref1","first-page":"146","article-title":"Uber eine eigenartige Erkrankung der Hirnrinde","volume":"64","author":"Alzheimer","year":"1907","journal-title":"Allg Z Psychiat Psych-Gerichtl Med"},{"key":"10.3233\/JAD-179903_ref2","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000211873","article-title":"Miliare Nekrosen mit drusigen Wucherungen der Neurofibrillen, eine regelmabige Veranderung der Hirnrinde bei seniler Demenz","volume":"22","author":"Fischer","year":"1907","journal-title":"Monatsschr Psychiatr Neurol"},{"key":"10.3233\/JAD-179903_ref3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0022-510X(98)00128-2","article-title":"History of dementia and dementia in history: An overview","volume":"158","author":"Boller","year":"1998","journal-title":"J Neurol Sci"},{"key":"10.3233\/JAD-179903_ref4","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/archneur.1976.00500040001001","article-title":"The prevalence and malignancy of Alzheimer\u2019s disease: A major killer","volume":"33","author":"Katzman","year":"1976","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-179903_ref5","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.neurobiolaging.2006.06.021","article-title":"Is aging part of Alzheimer\u2019s disease, or is Alzheimer\u2019s disease part of aging?","volume":"28","author":"Swerdlow","year":"2007","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-179903_ref6","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nm0896-864","article-title":"Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer\u2019s disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer\u2019s disease","volume":"2","author":"Scheuner","year":"1996","journal-title":"Nat Med"},{"key":"10.3233\/JAD-179903_ref7","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.3233\/JAD-179903_ref8","unstructured":"Alzheimer\u2019s Association (2017) 2017 Alzheimer\u2019s Disease Facts and Figures. https:\/\/www.alz.org\/documents_custom\/2017-facts-and-figures.pdf"},{"key":"10.3233\/JAD-179903_ref9","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1074\/jbc.271.8.4077","article-title":"Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains","volume":"271","author":"Kuo","year":"1996","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-179903_ref10","doi-asserted-by":"crossref","first-page":"10417","DOI":"10.1073\/pnas.1834302100","article-title":"Alzheimer\u2019s disease-affected brain: resence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss","volume":"100","author":"Gong","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-179903_ref11","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.nbd.2009.05.024","article-title":"Soluble fibrillar oligomer levels are elevated in Alzheimer\u2019s disease brain and correlate with cognitive dysfunction","volume":"35","author":"Tomic","year":"2009","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JAD-179903_ref12","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M","article-title":"Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer\u2019s disease","volume":"46","author":"McLean","year":"1999","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-179903_ref13","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.neuron.2010.04.031","article-title":"Probing the biology of Alzheimer\u2019s disease in mice","volume":"66","author":"Ashe","year":"2010","journal-title":"Neuron"},{"key":"10.3233\/JAD-179903_ref14","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.bbr.2008.02.016","article-title":"Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior","volume":"192","author":"Selkoe","year":"2008","journal-title":"Behav Brain Res"},{"key":"10.3233\/JAD-179903_ref15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0006-8993(01)03058-X","article-title":"Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus","volume":"924","author":"Wang","year":"2002","journal-title":"Brain Res"},{"key":"10.3233\/JAD-179903_ref16","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.1073\/pnas.95.11.6448","article-title":"Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins","volume":"95","author":"Lambert","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-179903_ref17","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1126\/science.1079469","article-title":"Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis","volume":"300","author":"Kayed","year":"2003","journal-title":"Science"},{"key":"10.3233\/JAD-179903_ref18","doi-asserted-by":"crossref","first-page":"32046","DOI":"10.1074\/jbc.M201750200","article-title":"Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability","volume":"277","author":"Dahlgren","year":"2002","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-179903_ref19","doi-asserted-by":"crossref","first-page":"14745","DOI":"10.1073\/pnas.0905127106","article-title":"Structure-neurotoxicity relationships of amyloid beta-protein oligomers","volume":"106","author":"Ono","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-179903_ref20","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1113\/jphysiol.2005.103754","article-title":"Effects of secreted oligomers of amyloid beta-protein on hippocampal synaptic plasticity: A potent role for trimers","volume":"572","author":"Townsend","year":"2006","journal-title":"J Physiol"},{"key":"10.3233\/JAD-179903_ref21","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/416535a","article-title":"Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo","volume":"416","author":"Walsh","year":"2002","journal-title":"Nature"},{"key":"10.3233\/JAD-179903_ref22","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nm1782","article-title":"Amyloid-beta protein dimers isolated directly from Alzheimer\u2019s brains impair synaptic plasticity and memory","volume":"14","author":"Shankar","year":"2008","journal-title":"Nat Med"},{"key":"10.3233\/JAD-179903_ref23","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nn1372","article-title":"Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function","volume":"8","author":"Cleary","year":"2005","journal-title":"Nat Neurosci"},{"key":"10.3233\/JAD-179903_ref24","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nature04533","article-title":"A specific amyloid-beta protein assembly in the brain impairs memory","volume":"440","author":"Lesne S Koh","year":"2006","journal-title":"Nature"},{"key":"10.3233\/JAD-179903_ref25","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1126\/science.1197623","article-title":"Decreased clearance of CNS beta-amyloid in Alzheimer\u2019s disease","volume":"330","author":"Mawuenyega","year":"2010","journal-title":"Science"},{"key":"10.3233\/JAD-179903_ref26","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer\u2019s disease: Recommendations from the National Institute on Aging and the Alzheimer\u2019s Association workgroup","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-179903_ref27","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","article-title":"Hypothetical model of dynamic biomarkers of the Alzheimer\u2019s pathological cascade","volume":"9","author":"Jack","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-179903_ref28","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1001\/archneur.65.11.1509","article-title":"Frequent amyloid deposition without significant cognitive impairment among the elderly","volume":"65","author":"Aizenstein","year":"2008","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-179903_ref29","doi-asserted-by":"crossref","first-page":"006213","DOI":"10.1101\/cshperspect.a006213","article-title":"Brain imaging in Alzheimer disease.a","volume":"2","author":"Johnson","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.3233\/JAD-179903_ref30","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.21610","article-title":"Cerebrospinal fluid biomarker signature in Alzheimer\u2019s disease neuroimaging initiative","volume":"65","author":"Shaw","year":"2009","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-179903_ref31","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ana.22248","article-title":"Longitudinal assessment of A\u03b2 and cognition in aging and Alzheimer disease","volume":"69","author":"Villemagne","year":"2011","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-179903_ref32","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1001\/archneur.62.5.758","article-title":"Predictors of preclinical Alzheimer disease and dementia: A clinicopathologic study","volume":"62","author":"Galvin","year":"2005","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-179903_ref33","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/ana.21031","article-title":"Impact of Alzheimer\u2019s pathology on cognitive trajectories in nondemented elderly","volume":"60","author":"Driscoll","year":"2006","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-179903_ref34","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1016\/j.neurobiolaging.2009.12.008","article-title":"Lack of association between 11C-PiB and longitudinal brain atrophy in non-demented older individuals","volume":"32","author":"Driscoll","year":"2011","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-179903_ref35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12035-008-8019-y","article-title":"The ART of loss: A\u03b2 Imaging in the evaluation of Alzheimer\u2019s disease and other dementias","volume":"38","author":"Villemagne","year":"2008","journal-title":"Mol Neurobiol"},{"key":"10.3233\/JAD-179903_ref36","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1212\/01.wnl.0000261919.22630.ea","article-title":"Imaging \u03b2-amyloid burden in aging and dementia","volume":"68","author":"Rowe","year":"2007","journal-title":"Neurology"},{"key":"10.3233\/JAD-179903_ref37","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1001\/archneur.64.3.416","article-title":"Incidence of dementia in mild cognitive impairment in the cardiovascular health study cognition study","volume":"64","author":"Lopez","year":"2007","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-179903_ref38","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0140-6736(08)61075-2","article-title":"Long-term effects of Abeta42 immunization in Alzheimer\u2019s disease: Follow-up of a randomized, placebo-controlled phase I trial","volume":"372","author":"Holmes","year":"2008","journal-title":"Lancet"},{"key":"10.3233\/JAD-179903_ref39","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12877-017-0601-6","article-title":"Cognitive function in very old men does not correlate to biomarkers of Alzheimer\u2019s disease","volume":"17","author":"Velickaite","year":"2017","journal-title":"BMC Geriatrics"},{"key":"10.3233\/JAD-179903_ref40","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/nm.2460","article-title":"Resolving controversies on the path to Alzheimer\u2019s therapeutics","volume":"17","author":"Selkoe","year":"2011","journal-title":"Nat Med"},{"key":"10.3233\/JAD-179903_ref41","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.biopsych.2010.09.020","article-title":"What can be inferred from the interruption of the semagacestat trial for treatment of Alzheimer\u2019s disease?","volume":"68","author":"Cummings","year":"2010","journal-title":"Biol Psychiatry"},{"key":"10.3233\/JAD-179903_ref42","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0197-4580(00)00211-6","article-title":"Copernicus revisited: Amyloid beta in Alzheimer\u2019s disease","volume":"22","author":"Joseph","year":"2001","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-179903_ref43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0002-9440(10)63936-3","article-title":"Do neurons have a choice in death?","volume":"158","author":"Perry","year":"2001","journal-title":"Am J Pathol"},{"key":"10.3233\/JAD-179903_ref44","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.molmed.2005.02.008","article-title":"Tau phosphorylation in Alzheimer\u2019s disease: Pathogen or protector?","volume":"11","author":"Lee","year":"2005","journal-title":"Trends Mol Med"},{"key":"10.3233\/JAD-179903_ref45","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/NEN.0b013e318177eaf4","article-title":"Alzheimer disease pathology as a host response","volume":"67","author":"Castellani","year":"2008","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JAD-179903_ref46","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00401-006-0071-y","article-title":"Neuropathology of Alzheimer\u2019s disease: Pathognomonic but not pathogenic","volume":"111","author":"Castellani","year":"2006","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-179903_ref47","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/nn.2583","article-title":"Amyloid-\u03b2-induced neuronal dysfunction in Alzheimer\u2019s disease: From synapses toward neural networks","volume":"13","author":"Palop","year":"2010","journal-title":"Nat Neurosci"},{"key":"10.3233\/JAD-179903_ref48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.arr.2015.04.003","article-title":"From cellular senescence to Alzheimer\u2019s disease: The role of telomere shortening","volume":"22","author":"Boccardi","year":"2015","journal-title":"Ageing Res Rev"},{"key":"10.3233\/JAD-179903_ref49","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1212\/01.wnl.0000240127.89601.83","article-title":"Aging of the brain, entropy, and Alzheimer disease","volume":"67","author":"Drachman","year":"2006","journal-title":"Neurology"},{"key":"10.3233\/JAD-179903_ref50","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s10522-014-9532-1","article-title":"Are there roles for brain cell senescence in aging and neurodegenerative disorders?","volume":"15","author":"Tan","year":"2014","journal-title":"Biogerontology"},{"key":"10.3233\/JAD-179903_ref51","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.exger.2014.09.018","article-title":"Cellular senescence and the aging brain","volume":"68","author":"Chinta","year":"2015","journal-title":"Exp Gerontol"},{"key":"10.3233\/JAD-179903_ref52","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1089\/rej.2006.9096","article-title":"Evidence that aging and amyloid promote microglial cell senescence","volume":"10","author":"Flanary","year":"2007","journal-title":"Rejuvenation Res"},{"key":"10.3233\/JAD-179903_ref53","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s40478-014-0142-6","article-title":"Microglial pathology","volume":"2","author":"Streit","year":"2014","journal-title":"Acta Neuropathol Commun"},{"issue":"Suppl 2","key":"10.3233\/JAD-179903_ref54","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/jnc.13509","article-title":"Bioenergetics and metabolism: A bench to bedside perspective","volume":"139","author":"Swerdlow","year":"2016","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-179903_ref55","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0531-5565(02)00151-1","article-title":"Aging and the human neocortex","volume":"38","author":"Pakkenberg","year":"2003","journal-title":"Exp Gerontol"},{"key":"10.3233\/JAD-179903_ref56","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s12640-011-9272-9","article-title":"Alzheimer\u2019s disease pathologic cascades: Who comes first, what drives what","volume":"22","author":"Swerdlow","year":"2012","journal-title":"Neurotox Res"},{"key":"10.3233\/JAD-179903_ref57","first-page":"261","article-title":"Mitochondria and Parkinson\u2019s disease","volume":"2011","author":"Simon","year":"2012","journal-title":"Parkinsons Dis"},{"key":"10.3233\/JAD-179903_ref58","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.mam.2011.10.005","article-title":"Shift in brain metabolism in late onset Alzheimer\u2019s disease: Implications for biomarkers and therapeutic interventions","volume":"32","author":"Yao","year":"2011","journal-title":"Mol Aspects Med"},{"key":"10.3233\/JAD-179903_ref59","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3233\/JAD-2007-12208","article-title":"Amyloid-\u03b2-induced mitochondrial dysfunction","volume":"12","author":"Chena","year":"2007","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-179903_ref60","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S1474-4422(10)70306-9","article-title":"Early-onset versus late-onset Alzheimer\u2019s disease: The case of the missing APOE\u025b4 allele","volume":"10","author":"Van der Flier","year":"2011","journal-title":"Lancet Neurol"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-179903","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:07:33Z","timestamp":1777370853000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-179903"}},"subtitle":[],"editor":[{"given":"G.","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"J.","family":"Avila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"P.I.","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"A.A.","family":"Sorensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"M.","family":"Tabaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,6,12]]},"references-count":60,"journal-issue":{"issue":"s1"},"URL":"https:\/\/doi.org\/10.3233\/jad-179903","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,12]]}}}